These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3631918)

  • 1. Cholinergic-dependent cognitive deficits in Parkinson's disease.
    Dubois B; Danzé F; Pillon B; Cusimano G; Lhermitte F; Agid Y
    Ann Neurol; 1987 Jul; 22(1):26-30. PubMed ID: 3631918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
    Dubois B; Pilon B; Lhermitte F; Agid Y
    Ann Neurol; 1990 Aug; 28(2):117-21. PubMed ID: 2221841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and cholinergic modulation of the transient magnetic 40-Hz auditory response.
    Ahveninen J; Jääskeläinen IP; Kaakkola S; Tiitinen H; Pekkonen E
    Neuroimage; 2002 Jan; 15(1):153-8. PubMed ID: 11771983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
    Araujo JA; Studzinski CM; Milgram NW
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive deficits in Parkinson's disease].
    Guillard A; Fénelon G; Mahieux F
    Rev Neurol (Paris); 1991; 147(5):337-55. PubMed ID: 1853032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
    Bédard MA; Pillon B; Dubois B; Duchesne N; Masson H; Agid Y
    Brain Cogn; 1999 Jul; 40(2):289-313. PubMed ID: 10413563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Fraraccio M; Ptito A; Sadikot A; Panisset M; Dagher A
    Arch Clin Neuropsychol; 2008 Jul; 23(4):399-408. PubMed ID: 18394859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive deficits in Parkinson's disease].
    van Spaendonck KP; Berger HJ; Horstink MW; Cools AR
    Tijdschr Gerontol Geriatr; 1998 Aug; 29(4):189-95. PubMed ID: 9746934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
    Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN
    Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everyday cognitive failures and memory problems in Parkinson's patients without dementia.
    Poliakoff E; Smith-Spark JH
    Brain Cogn; 2008 Aug; 67(3):340-50. PubMed ID: 18358582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.